Phase II trial of weekly teriparatide [ZP-PTH] for the treatment of severe osteoporosis

Trial Profile

Phase II trial of weekly teriparatide [ZP-PTH] for the treatment of severe osteoporosis

Planning
Phase of Trial: Phase II

Latest Information Update: 01 Oct 2015

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Oct 2015 New trial record
    • 28 Sep 2015 According to a media release, Zosano Pharma plans to initiate this trial in the first of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top